Jun Nie

521 total citations
31 papers, 392 citations indexed

About

Jun Nie is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Jun Nie has authored 31 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Jun Nie's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jun Nie is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jun Nie collaborates with scholars based in China, Ethiopia and United States. Jun Nie's co-authors include Weiheng Hu, Xiangjuan Ma, Jindi Han, Guangming Tian, Di Wu, Ling Dai, Xiaoling Chen, Sen Han, Jie Zhang and Jian Fang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

Jun Nie

27 papers receiving 384 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jun Nie 266 149 105 69 62 31 392
Norishige Iizuka 101 0.4× 131 0.9× 157 1.5× 36 0.5× 47 0.8× 27 399
Chaonong Cai 121 0.5× 56 0.4× 107 1.0× 94 1.4× 32 0.5× 20 332
Atsuko Umezawa 181 0.7× 106 0.7× 97 0.9× 46 0.7× 15 0.2× 12 320
Cigdem Ussakli 155 0.6× 72 0.5× 111 1.1× 73 1.1× 26 0.4× 10 308
F. R. Hirsch 247 0.9× 222 1.5× 220 2.1× 71 1.0× 18 0.3× 26 449
Ryan Geschwindt 80 0.3× 137 0.9× 94 0.9× 37 0.5× 30 0.5× 15 337
Christina Neppl 83 0.3× 80 0.5× 106 1.0× 43 0.6× 63 1.0× 15 294
Jieer Ying 146 0.5× 56 0.4× 99 0.9× 62 0.9× 34 0.5× 22 270
Luka Ozretić 344 1.3× 105 0.7× 215 2.0× 44 0.6× 24 0.4× 13 516

Countries citing papers authored by Jun Nie

Since Specialization
Citations

This map shows the geographic impact of Jun Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Nie more than expected).

Fields of papers citing papers by Jun Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Nie. The network helps show where Jun Nie may publish in the future.

Co-authorship network of co-authors of Jun Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Nie. A scholar is included among the top collaborators of Jun Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Nie. Jun Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Wenli, Sen Han, Lan Mi, et al.. (2025). Immune checkpoint inhibitor-related myocarditis in patients with lung cancer. BMC Cancer. 25(1). 685–685. 3 indexed citations
2.
Tian, Guangming, Jun Nie, Ling Dai, et al.. (2025). Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China. Frontiers in Oncology. 15. 1577607–1577607.
3.
4.
Zhao, You, Weiwen Zhou, Weiping Luo, & Jun Nie. (2024). Analysis of Risk Factors for Poor Drainage of Ureteral Stents after Radical Cystectomy with Cutaneous Ureterostomy: A Retrospective Study. Archivos Españoles de Urología. 77(7). 805–805. 1 indexed citations
5.
Wang, Yang, Jun Nie, Ling Dai, et al.. (2023). Construction of an endoplasmic reticulum stress-related signature in lung adenocarcinoma by comprehensive bioinformatics analysis. BMC Pulmonary Medicine. 23(1). 172–172. 5 indexed citations
6.
Tian, Guangming, Xinliang Zhao, Jun Nie, et al.. (2022). The overall survival benefit in Chinese ALK+ NSCLC patients received targeted therapies. Journal of Thoracic Disease. 14(6). 2201–2212. 1 indexed citations
7.
Wang, Yang, Jun Nie, Ling Dai, et al.. (2021). Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC. Cancer Immunology Immunotherapy. 71(2). 267–276. 4 indexed citations
8.
Chen, Xiaoling, Jun Nie, Ling Dai, et al.. (2021). Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China. Frontiers in Oncology. 11. 607531–607531. 28 indexed citations
9.
Ma, Xu, Jun Nie, Weiheng Hu, et al.. (2020). Diagnosis and Treatment Characteristics of Lung Cancer Patients with Venous Thromboembolism. SHILAP Revista de lepidopterología.
10.
Wu, Di, Jun Nie, Weiheng Hu, et al.. (2020). A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer. International Journal of Cancer. 147(12). 3453–3460. 29 indexed citations
11.
Wang, Yang, Jun Nie, Ling Dai, et al.. (2018). Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma. Thoracic Cancer. 10(1). 17–23. 7 indexed citations
12.
Hu, Weiheng, Jian Fang, Jun Nie, et al.. (2017). Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.. Journal of Clinical Oncology. 35(15_suppl). e20574–e20574.
13.
Chen, Ceshi, Qiangming Sun, Jing Wu, et al.. (2016). The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer. OncoTargets and Therapy. Volume 9. 5737–5750. 28 indexed citations
14.
Hu, Weiheng, Jian Fang, Jun Nie, et al.. (2016). Efficacy and safety of extended use of platinum-based doublet chemotherapy plus endostatin in patients with advanced nonsmall cell lung cancer. Medicine. 95(28). e4183–e4183. 11 indexed citations
15.
Wu, Di, Jian Fang, Jun Nie, et al.. (2015). [Effects of Local Radiation Combined with Chemotherapy in the treatment of 
Patients with Extensive-stage Small Cell Lung Cancer].. SHILAP Revista de lepidopterología. 18(5). 272–9. 2 indexed citations
16.
Zhang, Jie, Jing Gao, Yanyan Li, et al.. (2015). Circulating PD‐L1 in NSCLC patients and the correlation between the level of PD‐L1 expression and the clinical characteristics. Thoracic Cancer. 6(4). 534–538. 109 indexed citations
17.
Zhang, Jie, Jian Fang, Jun Nie, et al.. (2015). Dynamic changes of circulating tumor cells during chemotherapy as a prognostic factor in patients with advanced lung cancer.. Journal of Clinical Oncology. 33(15_suppl). e22024–e22024.
18.
Zhang, Jie, Shaolei Li, Jindi Han, et al.. (2014). Retrospective study of surgery versus non‐surgical management in limited‐disease small cell lung cancer. Thoracic Cancer. 5(5). 405–410. 10 indexed citations
19.
Hu, Weiheng, Jian Fang, Jun Nie, et al.. (2014). Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen fails. Cancer Chemotherapy and Pharmacology. 73(6). 1129–1136. 4 indexed citations
20.
Bai, Yang, Ying-Chun Dai, Jiandong Li, et al.. (2004). Acute diarrhea during army field exercise in southern China. World Journal of Gastroenterology. 10(1). 127–127. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norishige Iizuka Breakdown of academic impact, for papers by Chaonong Cai Breakdown of academic impact, for papers by Atsuko Umezawa Breakdown of academic impact, for papers by Cigdem Ussakli Breakdown of academic impact, for papers by F. R. Hirsch Breakdown of academic impact, for papers by Ryan Geschwindt Breakdown of academic impact, for papers by Christina Neppl Breakdown of academic impact, for papers by Jieer Ying Breakdown of academic impact, for papers by Luka Ozretić
Rankless by CCL
2026